HF
ICPT

HRT Financial’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

HRT Financial’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-135,438
Closed -$1.89M – 3447
2022
Q3 		$1.89M Buy
135,438
+91,644
+209% +$1.48M 0.02% 619
2022
Q2 		$604K Buy
43,794
+6,739
+18% +$108K 0.01% 1350
2022
Q1 		$602K Sell
37,055
-65,269
-64% -$1.02M ﹤0.01% 1501
2021
Q4 		$1.67M Buy
102,324
+51,684
+102% +$871K 0.01% 767
2021
Q3 		$752K Buy
+50,640
New +$810K ﹤0.01% 1576

Other funds holding ICPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HRT Financial's ICPT Position: Q4 2022 in Review

HRT Financial sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2022, closing a stake of 135,438 shares — an estimated $1.89M sold.

HRT Financial first reported a position in ICPT in Q3 2021 and held it in 5 quarters. The position peaked at $1.89M in Q3 2022. 144 funds tracked by Wall St. Rank hold ICPT as of Q4 2022.

  • HRT Financial reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • HRT Financial sold 135,438 Intercept Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1.89M.
  • HRT Financial first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2021 and held it in 5 quarters.
  • HRT Financial's Intercept Pharmaceuticals, Inc. position peaked at $1.89M in Q3 2022.
  • 144 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2022.

Based on HRT Financial's 13F filing for Q4 2022, filed 10 Feb 2023.